close
close

Pharmaceutical Grade Sodium Bicarbonate Industry Set for 3.5% CAGR as E-Commerce and AI Reshape Market

Posted on by darion

According to Future Market Insights (FMI), the global demand for pharmaceutical grade sodium bicarbonate is expected to be $274.8 million in 2024 and $387.7 million by 2034. The market is expected to grow at a CAGR of 3.5% until 2034.

The global pharmaceutical grade sodium bicarbonate market is driven by the growing consumption of sodium bicarbonate by the pharmaceutical industry, particularly as an active pharmaceutical ingredient (API). It is widely used in the treatment of metabolic acidosis, hemodialysis, cardiac arrest, extracorporeal circulation, and uncontrolled diabetes.

The growing geriatric population is expected to drive the demand for sodium-based drugs. API is expected to become a dominant major ingredient in drug formulations, expanding the options for various drugs. Moreover, the use of sodium bicarbonate for hemodialysis is also expected to increase during the forecast period.

Research and development is focused on new applications for pharmaceutical-grade sodium bicarbonate. A study by the University of Liverpool and Karolinska Institute in Sweden found that giving women pharmaceutical-grade sodium bicarbonate in combination with oxytocin increased their chances of having a natural vaginal birth by 17%. This research aims to drive growth and open up new applications for pharmaceutical-grade sodium bicarbonate.

View Full Report!

Key findings from the Pharmaceutical Grade Sodium Bicarbonate Market Report:

  • The pharmaceutical grade sodium bicarbonate market is expected to reach $387.7 million until 2034.
  • The market is expected to grow at a CAGR of 3.5% until 2034.
  • The pharmaceutical grade sodium bicarbonate market in China is expected to grow at a CAGR of 3.9% until 2034.
  • The United States is expected to grow at a CAGR of 2% in the year 2034.
  • The pharmaceutical grade sodium bicarbonate market is expected to reach USD 372.4 million, growing at a compound annual growth rate (CAGR) of 3.5% during the forecast period from 2023 to 2033.
  • Considering the grade, the coarse segment is expected to have a market share of 78.2% in 2024.

“Government policies such as foreign direct investment, healthcare facilities and infrastructure development programs are aimed at increasing revenues in the global pharmaceutical grade sodium bicarbonate market. E-commerce dominates the pharmaceutical-grade sodium bicarbonate market, prompting companies to invest in robust strategies to expand reach and improve customer service.” – Nikhil Kaitwade (VP, Future Market Insights, Inc.) says

Competitive Landscape

The global pharmaceutical-grade sodium bicarbonate market is dominated by leading producers, with top-tier companies developing high-quality pharmaceutical-grade sodium bicarbonate and mining technologies.

Leading companies are focusing on new product launches, collaborations, mergers, acquisitions and joint ventures to distribute their products in healthcare facilities. Other companies are conducting extensive research and development to introduce innovative sodium bicarbonate medicines for various conditions. The market is expanding geographically to meet the needs of a larger consumer base, generating revenue through potential applications.

For example,

  • In 2023 Nephron Pharmaceuticals Corporation introduced an 8.4% sodium bicarbonate solution in a syringe as its first COC product, further driving growth at its Nephron 503B outsourcing facility.
  • In 2024 Akums Drugs & Pharmaceuticals Ltd has launched a chewable tablet of sodium alginate and potassium bicarbonate as an advanced gastric acid neutralising agent for the treatment of reflux, approved by the Drug Controller General of India.

Leading Pharmaceutical Grade Sodium Bicarbonate Brands

  • Dr. Paul Lohmann GmbH KG
  • GHCL Limited
  • CIECH S.A.
  • Natural Soda LLC
  • Jost Chemical Co.
  • Tornox Alkali Corporation
  • Tata Chemicals
  • Solvay S.A.
  • Novocarb

Key segments of the market report

By class:

In terms of quality, the industry was divided into fine and coarse classes.

By application:

Based on applications, the industry is divided into active pharmaceutical ingredients (APIs), excipients, antacids, hemodialysis, tablet coatings, toothpastes, and others.

By region:

Industry analysis was conducted in key countries in North America, Latin America, Western Europe, Eastern Europe, South Asia, East Asia and the Middle East and Africa.

Read the full study: https://www.globenewswire.com/news-release/2024/07/01/2906964/0/en/Rising-Usage-of-Sodium-Bicarbonate-in-Cleaning-Solutions-and-Systemic-Alkalizer-to- Surge-Pharma-Grade-Sodium-Bicarbonate-Market-at-3-5-CAGR-to-2034-Future-Market-Insights-Inc.html

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, Stevie Award winner and member of the Greater New York Chamber of Commerce) offers in-depth insights into the factors driving market demand. FMI is a leading global provider of market intelligence, advisory services, consulting and events for the packaging, food and beverage, consumer technology, healthcare, industrial and chemical markets. With a large team of ~400 analysts worldwide, FMI provides global, regional and local expertise on various industry domains and trends in over 110 countries.

Contact us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Apartment 401, Newark, Delaware – 19713, USA
Phone: +1-845-579-5705
For commercial inquiries: [email protected]
Website: https://www.futuremarketinsights.com
LinkedIn | Twitter| Blogs | YouTube